"This Is Not Your Father's FDA," on Nov. 18, comes with a 30-point checklist quality teams can use to test their own readiness
ASHLAND, Mass., Nov. 16, 2026 /PRNewswire/ -- Medicept founder F. David Rothkopf will take the stage at MEDevice Silicon Valley in San Jose, Calif., on Wednesday, Nov. 18, with a simple message for medical device teams: if your picture of an FDA inspection is even a few years old, it is out of date. His session, "This Is Not Your Father's FDA," runs from 10:45 to 11:30 a.m. PST in the Design Studio Theater (805).
What changed
On Feb. 2, 2026, FDA's Quality Management System Regulation (QMSR) took effect, and the agency retired QSIT, the inspection approach quality teams had prepared for since the late 1990s. Investigators now start from a company's own risk management files and follow the risks to patients and users through the quality system. Records that used to stay out of view, including management reviews, internal audits and supplier audits, are now open to them.
Rothkopf has seen the shift up close. He has spent 35 years in medical device development and regulatory strategy, has carried out more than 400 ISO 13485 and FDA-style audits, and founded Medicept in 1996. This San Jose talk follows earlier stops this year at MEDevice Boston and MD&M Midwest.
In 45 minutes, he will walk through:
- how an inspection runs today, and why the old QSIT playbook no longer fits;
- which records investigators can now ask for, and how to get management review and audit files ready;
- why risk management now sits at the center of an inspection, not only in design; and
- what to fix first if your last FDA inspection was before February 2026.
"Most quality teams prepared for an FDA inspection the same way for 25 years, and that preparation no longer matches what happens when the investigator arrives," said F. David Rothkopf, founder of Medicept. "The rules changed in February, but the bigger change is in what investigators ask for and how they follow a problem through the system. I want people to leave this session knowing what to fix before the notice of inspection arrives. No one can promise how an inspection will end, but nobody should be surprised by how it is run."
A checklist to take back to the office
To go with the session, Medicept has published the Inspection Readiness Checklist: FDA Inspections After QSIT, a 30-point self-assessment for quality teams. It starts with risk management, moves through the six quality system areas and the other FDA requirements investigators now cover, and ends with a score that shows where a team stands. One test from the list: pick a top patient risk and trace it from design inputs to postmarket feedback, with each record in hand in under 10 minutes.
Patients are waiting
Inspection readiness is one part of the work. As an integrated lifecycle partner, Medicept brings regulatory, quality, clinical and commercialization expertise together in one team, with an in-house clinical research organization (CRO), so that every decision lines up across the product lifecycle. Its clients range from emerging companies that need clarity and momentum to established enterprises seeking consistency and strategic expertise. The firm refreshed its brand in August 2026 around the idea that guides the work: patients are waiting.
Going to MEDevice Silicon Valley? Join the session on Wednesday at 10:45 a.m. PST. To talk with the Medicept team about getting ready for your next inspection, visit medicept.com/contact.
About Medicept
Medicept is your trusted integrated lifecycle partner bringing global expertise in regulatory, quality, clinical, and commercialization together in one team. Our experts reduce risk, eliminate costly gaps, and keep critical programs moving forward. Move ahead with confidence knowing every decision is aligned across the product lifecycle, helping you achieve key milestones and bring innovations to patients faster. Learn more at www.medicept.com.
Media Relations and Company Contact
Medicept
200 Homer Ave, Ashland, MA 01721
Phone: +1 508 231 8842
Contact: https://www.medicept.com/contact
SOURCE Medicept

Share this article